Rapid Restoration of Cognition in Alzheimer's Transgenic Mice with 8-Hydroxy Quinoline Analogs Is Associated with Decreased Interstitial A[beta]

As a disease-modifying approach for Alzheimer's disease (AD), clioquinol (CQ) targets β-amyloid (Aß) reactions with synaptic Zn and Cu yet promotes metal uptake. Here we characterize the second-generation 8-hydroxy quinoline analog PBT2, which also targets metal-induced aggregation of Aß, but i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuron (Cambridge, Mass.) Mass.), 2008-07, Vol.59 (1), p.43
Hauptverfasser: Adlard, Paul A, Cherny, Robert A, Finkelstein, David I, Gautier, Elisabeth, Robb, Elysia, Cortes, Mikhalina, Volitakis, Irene, Liu, Xiang, Smith, Jeffrey P, Perez, Keyla, Laughton, Katrina, Li, Qiao-Xin, Charman, Susan A, Nicolazzo, Joseph A, Wilkins, Simon, Deleva, Karolina, Lynch, Toni, Kok, Gaik, Ritchie, Craig W, Tanzi, Rudolph E, Cappai, Roberto, Masters, Colin L, Barnham, Kevin J, Bush, Ashley I
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page 43
container_title Neuron (Cambridge, Mass.)
container_volume 59
creator Adlard, Paul A
Cherny, Robert A
Finkelstein, David I
Gautier, Elisabeth
Robb, Elysia
Cortes, Mikhalina
Volitakis, Irene
Liu, Xiang
Smith, Jeffrey P
Perez, Keyla
Laughton, Katrina
Li, Qiao-Xin
Charman, Susan A
Nicolazzo, Joseph A
Wilkins, Simon
Deleva, Karolina
Lynch, Toni
Kok, Gaik
Ritchie, Craig W
Tanzi, Rudolph E
Cappai, Roberto
Masters, Colin L
Barnham, Kevin J
Bush, Ashley I
description As a disease-modifying approach for Alzheimer's disease (AD), clioquinol (CQ) targets β-amyloid (Aß) reactions with synaptic Zn and Cu yet promotes metal uptake. Here we characterize the second-generation 8-hydroxy quinoline analog PBT2, which also targets metal-induced aggregation of Aß, but is more effective as a Zn/Cu ionophore and has greater blood-brain barrier permeability. Given orally to two types of amyloid-bearing transgenic mouse models of AD, PBT2 outperformed CQ by markedly decreasing soluble interstitial brain Aß within hours and improving cognitive performance to exceed that of normal littermate controls within days. Nontransgenic mice were unaffected by PBT2. The current data demonstrate that ionophore activity, inhibition of in vitro metal-mediated Aß reactions, and blood-brain barrier permeability are indices that predict a potential disease-modifying drug for AD. The speed of recovery of the animals underscores the acutely reversible nature of the cognitive deficits associated with transgenic models of AD.
doi_str_mv 10.1016/j.neuron.2008.06.018
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1503672464</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3234829341</sourcerecordid><originalsourceid>FETCH-proquest_journals_15036724643</originalsourceid><addsrcrecordid>eNqNjs1Kw0AUhQdRsP68gYsLLlwlziTpJFmGamkXLizdiZQxuU0nxLl17gStT-EjG9QHcHX44OOcI8SVkrGSSt92scPBk4sTKYtY6liq4khMlCzzKFNleSwmsih1pJM8PRVnzJ2UKpuWaiK-VmZvG1ghB_ImWHJAW5hR6-wPWAdV_7lD-4r-hmHtjeMWna3hwdYI7zbsoIgWh8bTxwEeB-uotw6hcqanlmHJUDFTbU3A5le_w9qj4RGXLqDnMC6ZHqqnFwzm-UKcbE3PePmX5-J6fr-eLaK9p7dhvLnpaPBjO2_UVKY6TzKdpf-zvgESYl67</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1503672464</pqid></control><display><type>article</type><title>Rapid Restoration of Cognition in Alzheimer's Transgenic Mice with 8-Hydroxy Quinoline Analogs Is Associated with Decreased Interstitial A[beta]</title><source>Cell Press Free Archives</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Adlard, Paul A ; Cherny, Robert A ; Finkelstein, David I ; Gautier, Elisabeth ; Robb, Elysia ; Cortes, Mikhalina ; Volitakis, Irene ; Liu, Xiang ; Smith, Jeffrey P ; Perez, Keyla ; Laughton, Katrina ; Li, Qiao-Xin ; Charman, Susan A ; Nicolazzo, Joseph A ; Wilkins, Simon ; Deleva, Karolina ; Lynch, Toni ; Kok, Gaik ; Ritchie, Craig W ; Tanzi, Rudolph E ; Cappai, Roberto ; Masters, Colin L ; Barnham, Kevin J ; Bush, Ashley I</creator><creatorcontrib>Adlard, Paul A ; Cherny, Robert A ; Finkelstein, David I ; Gautier, Elisabeth ; Robb, Elysia ; Cortes, Mikhalina ; Volitakis, Irene ; Liu, Xiang ; Smith, Jeffrey P ; Perez, Keyla ; Laughton, Katrina ; Li, Qiao-Xin ; Charman, Susan A ; Nicolazzo, Joseph A ; Wilkins, Simon ; Deleva, Karolina ; Lynch, Toni ; Kok, Gaik ; Ritchie, Craig W ; Tanzi, Rudolph E ; Cappai, Roberto ; Masters, Colin L ; Barnham, Kevin J ; Bush, Ashley I</creatorcontrib><description>As a disease-modifying approach for Alzheimer's disease (AD), clioquinol (CQ) targets β-amyloid (Aß) reactions with synaptic Zn and Cu yet promotes metal uptake. Here we characterize the second-generation 8-hydroxy quinoline analog PBT2, which also targets metal-induced aggregation of Aß, but is more effective as a Zn/Cu ionophore and has greater blood-brain barrier permeability. Given orally to two types of amyloid-bearing transgenic mouse models of AD, PBT2 outperformed CQ by markedly decreasing soluble interstitial brain Aß within hours and improving cognitive performance to exceed that of normal littermate controls within days. Nontransgenic mice were unaffected by PBT2. The current data demonstrate that ionophore activity, inhibition of in vitro metal-mediated Aß reactions, and blood-brain barrier permeability are indices that predict a potential disease-modifying drug for AD. The speed of recovery of the animals underscores the acutely reversible nature of the cognitive deficits associated with transgenic models of AD.</description><identifier>ISSN: 0896-6273</identifier><identifier>EISSN: 1097-4199</identifier><identifier>DOI: 10.1016/j.neuron.2008.06.018</identifier><language>eng</language><publisher>Cambridge: Elsevier Limited</publisher><subject>Animal cognition ; Biotechnology ; Brain research ; Clinical trials ; Neuropathology ; Pathogenesis ; Plasma ; Rodents</subject><ispartof>Neuron (Cambridge, Mass.), 2008-07, Vol.59 (1), p.43</ispartof><rights>Copyright Elsevier Limited Jul 10, 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Adlard, Paul A</creatorcontrib><creatorcontrib>Cherny, Robert A</creatorcontrib><creatorcontrib>Finkelstein, David I</creatorcontrib><creatorcontrib>Gautier, Elisabeth</creatorcontrib><creatorcontrib>Robb, Elysia</creatorcontrib><creatorcontrib>Cortes, Mikhalina</creatorcontrib><creatorcontrib>Volitakis, Irene</creatorcontrib><creatorcontrib>Liu, Xiang</creatorcontrib><creatorcontrib>Smith, Jeffrey P</creatorcontrib><creatorcontrib>Perez, Keyla</creatorcontrib><creatorcontrib>Laughton, Katrina</creatorcontrib><creatorcontrib>Li, Qiao-Xin</creatorcontrib><creatorcontrib>Charman, Susan A</creatorcontrib><creatorcontrib>Nicolazzo, Joseph A</creatorcontrib><creatorcontrib>Wilkins, Simon</creatorcontrib><creatorcontrib>Deleva, Karolina</creatorcontrib><creatorcontrib>Lynch, Toni</creatorcontrib><creatorcontrib>Kok, Gaik</creatorcontrib><creatorcontrib>Ritchie, Craig W</creatorcontrib><creatorcontrib>Tanzi, Rudolph E</creatorcontrib><creatorcontrib>Cappai, Roberto</creatorcontrib><creatorcontrib>Masters, Colin L</creatorcontrib><creatorcontrib>Barnham, Kevin J</creatorcontrib><creatorcontrib>Bush, Ashley I</creatorcontrib><title>Rapid Restoration of Cognition in Alzheimer's Transgenic Mice with 8-Hydroxy Quinoline Analogs Is Associated with Decreased Interstitial A[beta]</title><title>Neuron (Cambridge, Mass.)</title><description>As a disease-modifying approach for Alzheimer's disease (AD), clioquinol (CQ) targets β-amyloid (Aß) reactions with synaptic Zn and Cu yet promotes metal uptake. Here we characterize the second-generation 8-hydroxy quinoline analog PBT2, which also targets metal-induced aggregation of Aß, but is more effective as a Zn/Cu ionophore and has greater blood-brain barrier permeability. Given orally to two types of amyloid-bearing transgenic mouse models of AD, PBT2 outperformed CQ by markedly decreasing soluble interstitial brain Aß within hours and improving cognitive performance to exceed that of normal littermate controls within days. Nontransgenic mice were unaffected by PBT2. The current data demonstrate that ionophore activity, inhibition of in vitro metal-mediated Aß reactions, and blood-brain barrier permeability are indices that predict a potential disease-modifying drug for AD. The speed of recovery of the animals underscores the acutely reversible nature of the cognitive deficits associated with transgenic models of AD.</description><subject>Animal cognition</subject><subject>Biotechnology</subject><subject>Brain research</subject><subject>Clinical trials</subject><subject>Neuropathology</subject><subject>Pathogenesis</subject><subject>Plasma</subject><subject>Rodents</subject><issn>0896-6273</issn><issn>1097-4199</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNqNjs1Kw0AUhQdRsP68gYsLLlwlziTpJFmGamkXLizdiZQxuU0nxLl17gStT-EjG9QHcHX44OOcI8SVkrGSSt92scPBk4sTKYtY6liq4khMlCzzKFNleSwmsih1pJM8PRVnzJ2UKpuWaiK-VmZvG1ghB_ImWHJAW5hR6-wPWAdV_7lD-4r-hmHtjeMWna3hwdYI7zbsoIgWh8bTxwEeB-uotw6hcqanlmHJUDFTbU3A5le_w9qj4RGXLqDnMC6ZHqqnFwzm-UKcbE3PePmX5-J6fr-eLaK9p7dhvLnpaPBjO2_UVKY6TzKdpf-zvgESYl67</recordid><startdate>20080710</startdate><enddate>20080710</enddate><creator>Adlard, Paul A</creator><creator>Cherny, Robert A</creator><creator>Finkelstein, David I</creator><creator>Gautier, Elisabeth</creator><creator>Robb, Elysia</creator><creator>Cortes, Mikhalina</creator><creator>Volitakis, Irene</creator><creator>Liu, Xiang</creator><creator>Smith, Jeffrey P</creator><creator>Perez, Keyla</creator><creator>Laughton, Katrina</creator><creator>Li, Qiao-Xin</creator><creator>Charman, Susan A</creator><creator>Nicolazzo, Joseph A</creator><creator>Wilkins, Simon</creator><creator>Deleva, Karolina</creator><creator>Lynch, Toni</creator><creator>Kok, Gaik</creator><creator>Ritchie, Craig W</creator><creator>Tanzi, Rudolph E</creator><creator>Cappai, Roberto</creator><creator>Masters, Colin L</creator><creator>Barnham, Kevin J</creator><creator>Bush, Ashley I</creator><general>Elsevier Limited</general><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>20080710</creationdate><title>Rapid Restoration of Cognition in Alzheimer's Transgenic Mice with 8-Hydroxy Quinoline Analogs Is Associated with Decreased Interstitial A[beta]</title><author>Adlard, Paul A ; Cherny, Robert A ; Finkelstein, David I ; Gautier, Elisabeth ; Robb, Elysia ; Cortes, Mikhalina ; Volitakis, Irene ; Liu, Xiang ; Smith, Jeffrey P ; Perez, Keyla ; Laughton, Katrina ; Li, Qiao-Xin ; Charman, Susan A ; Nicolazzo, Joseph A ; Wilkins, Simon ; Deleva, Karolina ; Lynch, Toni ; Kok, Gaik ; Ritchie, Craig W ; Tanzi, Rudolph E ; Cappai, Roberto ; Masters, Colin L ; Barnham, Kevin J ; Bush, Ashley I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_15036724643</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Animal cognition</topic><topic>Biotechnology</topic><topic>Brain research</topic><topic>Clinical trials</topic><topic>Neuropathology</topic><topic>Pathogenesis</topic><topic>Plasma</topic><topic>Rodents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Adlard, Paul A</creatorcontrib><creatorcontrib>Cherny, Robert A</creatorcontrib><creatorcontrib>Finkelstein, David I</creatorcontrib><creatorcontrib>Gautier, Elisabeth</creatorcontrib><creatorcontrib>Robb, Elysia</creatorcontrib><creatorcontrib>Cortes, Mikhalina</creatorcontrib><creatorcontrib>Volitakis, Irene</creatorcontrib><creatorcontrib>Liu, Xiang</creatorcontrib><creatorcontrib>Smith, Jeffrey P</creatorcontrib><creatorcontrib>Perez, Keyla</creatorcontrib><creatorcontrib>Laughton, Katrina</creatorcontrib><creatorcontrib>Li, Qiao-Xin</creatorcontrib><creatorcontrib>Charman, Susan A</creatorcontrib><creatorcontrib>Nicolazzo, Joseph A</creatorcontrib><creatorcontrib>Wilkins, Simon</creatorcontrib><creatorcontrib>Deleva, Karolina</creatorcontrib><creatorcontrib>Lynch, Toni</creatorcontrib><creatorcontrib>Kok, Gaik</creatorcontrib><creatorcontrib>Ritchie, Craig W</creatorcontrib><creatorcontrib>Tanzi, Rudolph E</creatorcontrib><creatorcontrib>Cappai, Roberto</creatorcontrib><creatorcontrib>Masters, Colin L</creatorcontrib><creatorcontrib>Barnham, Kevin J</creatorcontrib><creatorcontrib>Bush, Ashley I</creatorcontrib><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Neuron (Cambridge, Mass.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Adlard, Paul A</au><au>Cherny, Robert A</au><au>Finkelstein, David I</au><au>Gautier, Elisabeth</au><au>Robb, Elysia</au><au>Cortes, Mikhalina</au><au>Volitakis, Irene</au><au>Liu, Xiang</au><au>Smith, Jeffrey P</au><au>Perez, Keyla</au><au>Laughton, Katrina</au><au>Li, Qiao-Xin</au><au>Charman, Susan A</au><au>Nicolazzo, Joseph A</au><au>Wilkins, Simon</au><au>Deleva, Karolina</au><au>Lynch, Toni</au><au>Kok, Gaik</au><au>Ritchie, Craig W</au><au>Tanzi, Rudolph E</au><au>Cappai, Roberto</au><au>Masters, Colin L</au><au>Barnham, Kevin J</au><au>Bush, Ashley I</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rapid Restoration of Cognition in Alzheimer's Transgenic Mice with 8-Hydroxy Quinoline Analogs Is Associated with Decreased Interstitial A[beta]</atitle><jtitle>Neuron (Cambridge, Mass.)</jtitle><date>2008-07-10</date><risdate>2008</risdate><volume>59</volume><issue>1</issue><spage>43</spage><pages>43-</pages><issn>0896-6273</issn><eissn>1097-4199</eissn><abstract>As a disease-modifying approach for Alzheimer's disease (AD), clioquinol (CQ) targets β-amyloid (Aß) reactions with synaptic Zn and Cu yet promotes metal uptake. Here we characterize the second-generation 8-hydroxy quinoline analog PBT2, which also targets metal-induced aggregation of Aß, but is more effective as a Zn/Cu ionophore and has greater blood-brain barrier permeability. Given orally to two types of amyloid-bearing transgenic mouse models of AD, PBT2 outperformed CQ by markedly decreasing soluble interstitial brain Aß within hours and improving cognitive performance to exceed that of normal littermate controls within days. Nontransgenic mice were unaffected by PBT2. The current data demonstrate that ionophore activity, inhibition of in vitro metal-mediated Aß reactions, and blood-brain barrier permeability are indices that predict a potential disease-modifying drug for AD. The speed of recovery of the animals underscores the acutely reversible nature of the cognitive deficits associated with transgenic models of AD.</abstract><cop>Cambridge</cop><pub>Elsevier Limited</pub><doi>10.1016/j.neuron.2008.06.018</doi></addata></record>
fulltext fulltext
identifier ISSN: 0896-6273
ispartof Neuron (Cambridge, Mass.), 2008-07, Vol.59 (1), p.43
issn 0896-6273
1097-4199
language eng
recordid cdi_proquest_journals_1503672464
source Cell Press Free Archives; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Animal cognition
Biotechnology
Brain research
Clinical trials
Neuropathology
Pathogenesis
Plasma
Rodents
title Rapid Restoration of Cognition in Alzheimer's Transgenic Mice with 8-Hydroxy Quinoline Analogs Is Associated with Decreased Interstitial A[beta]
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T08%3A17%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rapid%20Restoration%20of%20Cognition%20in%20Alzheimer's%20Transgenic%20Mice%20with%208-Hydroxy%20Quinoline%20Analogs%20Is%20Associated%20with%20Decreased%20Interstitial%20A%5Bbeta%5D&rft.jtitle=Neuron%20(Cambridge,%20Mass.)&rft.au=Adlard,%20Paul%20A&rft.date=2008-07-10&rft.volume=59&rft.issue=1&rft.spage=43&rft.pages=43-&rft.issn=0896-6273&rft.eissn=1097-4199&rft_id=info:doi/10.1016/j.neuron.2008.06.018&rft_dat=%3Cproquest%3E3234829341%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1503672464&rft_id=info:pmid/&rfr_iscdi=true